TCT-164 Targeted Therapy With a Localized Abluminal Groove Low-Dose Sirolimus-Eluting Biodegradable-Polymer Coronary Stent: Subgroup Analysis of 5-Year Outcomes of the TARGET All Comers Randomized Trial
Kelbæk H, Lansky A, Xu B, Baumbach A, van Royen N, Knaapen P, Johnson T, Smits P, Vlachojannis G, Arkenbout K, Holmvang L, Janssens L, Ochala A, Wijns W. TCT-164 Targeted Therapy With a Localized Abluminal Groove Low-Dose Sirolimus-Eluting Biodegradable-Polymer Coronary Stent: Subgroup Analysis of 5-Year Outcomes of the TARGET All Comers Randomized Trial. Journal Of The American College Of Cardiology 2022, 80: b66. DOI: 10.1016/j.jacc.2022.08.193.Peer-Reviewed Original Research